Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Cardiology/Vascular Diseases | Psychiatry/Psychology | Pulmonary/Respiratory Diseases
Disease Category: Smoking Cessation
Location: United States, TN
Clinical Trial Details
Research Study Summary
Smoking Cessation Study
We are currently recruiting smokers who are really motivated to quit smoking. The purpose of the study is to evaluate the safety and effectiveness of three approved medications, Habitrol, Zyban and Chantix, in combination and compared to a placebo (no active ingredient). Requires 12 weekly visits.
Patient Inclusion Criteria:
- Participants must be 18-75 and smoke at least 10 cigarettes a day.
Patient Exclusion Criteria:
- Patients who have had an allergic reaction to a medication, have had a DUI, seizure or stroke, are not eligible to participate. In addition, there are certain medications which would exclude the patient from participating.
To Learn more
Both Male and Female
Date Last Changed:
July 18, 2013
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these